Given the role of the PTEN/AKT/mTOR pathway in cardiac hypertrophy and fibrosis (Sun et al., 2021), IGFBP2’s modulatory effect on PTEN may influence AF development. The gene discussed is IGFBP2; the disease is cardiac hypertrophy.